- Reference code :
- wf5266
- Published date :
-
22 August 2006
- Expired date :
-
07 January 2034
AstraZeneca today announced that it has completed the compulsory acquisition procedure under the Interim Regulations and now owns 100 percent of the issued share capital of CAT.
The Subsequent Offer Period has now ended and the Offer is closed for further acceptance.
Defined terms used in this announcement have the same meanings as in the Offer Document dated 23 May 2006.
-Ends-
22 August 2006
Enquiries:
AstraZeneca
Media Enquiries:
Steve Brown (London) +44 (0)20 7304 5033
Edel McCaffrey (London) +44 (0) 20 7304 5034
Staffan Ternby (Sweden) +46 8 553 26107
Analyst/Investor Enquiries:
Jonathan Hunt (London) +44 (0) 20 7304 5087
Jörgen Winroth (US) +1 212 579 0506
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD
- Stockholm
-
310.10 SEK
At 21-Nov-2009 10:24 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
